US Stock MarketDetailed Quotes
TENX Tenax Therapeutics
- 4.9200
- +0.0700+1.44%
Close Nov 22 16:00 ET
16.77MMarket Cap-377P/E (TTM)
4.9300High4.6800Low56.02KVolume4.8800Open4.8500Pre Close269.35KTurnover2.12%Turnover RatioLossP/E (Static)3.41MShares29.400052wk High0.17P/B13.00MFloat Cap2.770052wk Low--Dividend TTM2.64MShs Float21599978.4000Historical High--Div YieldTTM5.16%Amplitude2.7700Historical Low4.8080Avg Price1Lot Size
About Tenax Therapeutics Company
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.
Company Profile
SymbolTENX
Company NameTenax Therapeutics
Listing DateJan 15, 2010
Founded1967
CEOMr. Christopher T. Giordano
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address101 Glen Lennox Drive,Suite 300
CityChapel Hill
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27517
Phone1-919-855-2100
Websitehttp://www.tenaxthera.com
Company Executives
- Name
- Position
- Salary
- Christopher T. Giordano
- Director, President and Chief Executive Officer
- 644.77K
- Dr. Stuart Rich, M.D.
- Director and Chief Medical Officer
- 481.22K
- Lawrence R. Hoffman
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Gerald T. Proehl
- Chairman of the Board
- 88.50K
- Dr. June S. Almenoff, F.A.C.P.,M.D.,PhD
- Independent Director
- 59.50K
- Robyn M Hunter
- Independent Director
- 65.00K
- Dr. Michael Harvey Davidson, M.D.
- Independent Director
- 57.50K
- Dr. Declan Doogan, M.D.
- Independent Director
- 48.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data